Its administration decreased levels of 4-hydroxynonenal (a product of lipid peroxidation) in patients with cardiomyopathy (Malig et al., 2016)
10.1016/j.mcn.2009.09.013 19
Ingredients: Water, butylene glycol (1,3, butanediol), tocofersolan, hyaluronic acid, ethanol, caprylyl glycol, medium chain triglycerides, copper tripeptide-1 (GHK-Cu), highly purified phospholipids, natural mixed tocopherols, Psoralea corylifolia seed/leaf extract (Bakuchiol), Tetrahexyldecyl ascorbate, lavender essential oil, estriol, estradiol Other Ingredients: None
Kinematic and Kinetic Analysis Kinematic and kinetic analyses consistently demonstrate that excessive anterior tibial translation and internal tibial rotation significantly contribute to anterior cruciate ligament (ACL) strain
Jyotsana, N., Ta, K
Abstract L-DOPA remains a cornerstone treatment for Parkinsons disease and is increasingly recognized for its role in various neurological and neurodegenerative disorders